Presentation

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose

November 01, 2016

REGISTER for free or LOG IN to view this content

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Coronary

Presentation

TCT 2016

Plaque Modification

Up Next

Presentation

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Hasan Jilaihawi

November 01, 2016

More slides +

Presentation

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Presenter: Sanjog Kalra

November 01, 2016

Presentation

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Wilson Y. Szeto

November 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.